Latest Articles

All Latest Articles

149399 Articles

Douglas A. McIntyre | Jan 9, 2007 at 3:51 AM EST

Media Digest 1/9/2007 Reuters, WSJ, NYTimes, Barron’s, FT

According to The Wall Street Journal, GE (GE) is taking bids for its plastics unit which it hopes to sell…

Douglas A. McIntyre | Jan 9, 2007 at 3:34 AM EST

Just What the Semi Industry Doesn’t Need

By William Trent, CFA of Stock Market Beat UMC breaks ground on $5 billion 300mm fab – Semiconductor Fabtech UMC…

Douglas A. McIntyre | Jan 9, 2007 at 3:32 AM EST

Sprint the Latest Wireless Signal to Get Crossed

By William Trent, CFA of Stock Market Beat Last month, astute observers (defined as those with a pulse) could notice…

Douglas A. McIntyre | Jan 9, 2007 at 3:30 AM EST

If Your Broker Sells Mutual Funds, Run, Do Not Walk, To The Nearest Exit

From Chad Brand of Peridot Capitalist In a perfect world, stock brokers would actually earn their money. If they recommend…

Douglas A. McIntyre | Jan 9, 2007 at 3:26 AM EST

Take Off The Blinders

From Ticker Sense The over-riding theme among the major business headlines over the weekend was that the stronger than expected…

Douglas A. McIntyre | Jan 9, 2007 at 3:24 AM EST

Analyzing JP Morgan (JPM)

By Yaser Anwar, CSC of Equity Investment Ideas JPM has posted strong revenues in 2006, driven by solid investment banking…

Douglas A. McIntyre | Jan 9, 2007 at 3:22 AM EST

FIN 48: Slouching Toward Implementation

From AAO Weblog Last June, the FASB released an interpretation of Statement No. 109, which deals with income tax accounting.…

Douglas A. McIntyre | Jan 9, 2007 at 3:20 AM EST

“Known By The Company You Keep”

From AAO Weblog Maybe the Paulson Committee should be mindful of that old chestnut of moms everywhere. According to this…

Douglas A. McIntyre | Jan 9, 2007 at 3:19 AM EST

Monday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology POLYMEDIX INC [PYMX.OB] +60.00% SEATTLE GENETICS I [SGEN] +24.01% CYCLACEL PHARMACEUTI [CYCC] +20.93% INNCARDIO INC [ICDO.OB]…

Douglas A. McIntyre | Jan 9, 2007 at 3:16 AM EST

Biotech Indices Mixed as AMEX Gains, Nasdaq Slips

From BioHealth Investor by H.S. AyoubBioHealth Investor.com The major biotech indices were mixed on Monday. The AMEX Biotechnology Index (^BTK)…

Douglas A. McIntyre | Jan 9, 2007 at 2:45 AM EST

Cramer’s Biotech & Overlooked IPO Picks

On Monday night’s MAD MONEY show on CNBC Jim Cramer said there is noreason to wait for the J.P.Morgan Biotech…

Douglas A. McIntyre | Jan 8, 2007 at 6:48 PM EST

Cramer’s #1 Overlooked IPO of 2006

Cramer also wanted to review some IPO’s of 2006 that didn’t work out well at all to see if they…

Douglas A. McIntyre | Jan 8, 2007 at 6:27 PM EST

GE Finally Listens: Plastics For Sales

After years of investors and the press saying that GE (GE) would have to resturcture to get its stock moving…

Douglas A. McIntyre | Jan 8, 2007 at 6:24 PM EST

Cramer’s Scientific Instrument Purchase for Tomorrow Morning

Tonight Cramer said tonight on his MAD MONEY show on CNBC there is no reason to wait for the J.P.Morgan…

Douglas A. McIntyre | Jan 8, 2007 at 6:10 PM EST

Cramer’s Biotech Pick Ahead of the J.P. Morgan Biotech Conference

Tonight Cramer said tonight on his MAD MONEY show on CNBC there is no reason to wait for the J.P.Morgan…

1 … 9,871 9,872 9,873 9,874 9,875 … 9,960

Latest Articles

All Latest Articles

Media Digest 1/9/2007 Reuters, WSJ, NYTimes, Barron’s, FT

Just What the Semi Industry Doesn’t Need

Sprint the Latest Wireless Signal to Get Crossed

If Your Broker Sells Mutual Funds, Run, Do Not Walk, To The Nearest Exit

Take Off The Blinders

Analyzing JP Morgan (JPM)

FIN 48: Slouching Toward Implementation

“Known By The Company You Keep”

Monday’s Top Biotech and Medical Stocks

Biotech Indices Mixed as AMEX Gains, Nasdaq Slips

Cramer’s Biotech & Overlooked IPO Picks

Cramer’s #1 Overlooked IPO of 2006

GE Finally Listens: Plastics For Sales

Cramer’s Scientific Instrument Purchase for Tomorrow Morning

Cramer’s Biotech Pick Ahead of the J.P. Morgan Biotech Conference

Avoid Zillow: This Infrastructure Redirect Is a “No-Brainer” Buy as the Housing Market Stalls

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.

Avoid Zillow: This Infrastructure Redirect Is a “No-Brainer” Buy as the Housing Market Stalls

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Latest Articles

All Latest Articles

Media Digest 1/9/2007 Reuters, WSJ, NYTimes, Barron’s, FT

Just What the Semi Industry Doesn’t Need

Sprint the Latest Wireless Signal to Get Crossed

If Your Broker Sells Mutual Funds, Run, Do Not Walk, To The Nearest Exit

Take Off The Blinders

Analyzing JP Morgan (JPM)

FIN 48: Slouching Toward Implementation

“Known By The Company You Keep”

Monday’s Top Biotech and Medical Stocks

Biotech Indices Mixed as AMEX Gains, Nasdaq Slips

Cramer’s Biotech & Overlooked IPO Picks

Cramer’s #1 Overlooked IPO of 2006

GE Finally Listens: Plastics For Sales

Cramer’s Scientific Instrument Purchase for Tomorrow Morning

Cramer’s Biotech Pick Ahead of the J.P. Morgan Biotech Conference

Avoid Zillow: This Infrastructure Redirect Is a “No-Brainer” Buy as the Housing Market Stalls

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

Featured Reads

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.